CEO and Director · Apyx Medical Corp (APYX)

Charles Goodwin

FY2025 is the first fiscal year CompBrief holds for Charles Goodwin as a named executive officer of Apyx Medical; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,233,863

Salary $501,800Stock awards $0Bonus $426,530

1st of 4 named executive officers at Apyx Medical by FY2025 total.

4 named officers on file for Apyx Medical, FY2025

Charles Goodwin’s pay file — $29

  • 1 fiscal year of pay, line by line
  • APYX’s disclosed peer group of 11 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Apyx Medical’s whole pay program stands against its peers

  • Apyx Medical’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on APYX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 26, 2026 (DEF 14A).

Free

Get Charles Goodwin’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Charles Goodwin compensation by year

Apyx Medical Summary Compensation Table · the one fiscal year held
In US dollars, as Apyx Medical reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$501,800
Bonus$426,530
Stock awards$0
Option awards$281,993
Non-equity incentive$0
Pension and deferred compensation$0
All other$23,540
Total$1,233,863

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Apyx Medical Corp DEF 14A filed June 26, 2026, accession 0001437749-26-021840, and prior-year filings.

How this page was built: the Apyx Medical Corp filed document, accession 0001437749-26-021840. Every figure is read from that document and cited to the page and table it appears in. Filed June 26, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option486,000—$4.74

Per the Outstanding Equity Awards at Fiscal Year-End table in Apyx Medical Corp's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Apyx Medical’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Charles Goodwin · this pageCEO and Director$1,233,863
Mathew HillCFO, Treasurer and Secretary$851,815
Shawn RomanChief Operating Officer$538,553
Moshe CitronowiczSenior Vice President$534,260

The full Apyx Medical compensation record

free company brief

This page is one person within Apyx Medical's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Apyx Medical proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Apyx Medical's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Charles Goodwin's compensation dossier · One-time report. No refunds.